Berotralstat

N/A

Report date: 2024/07/11 11:35:43
NME

Base Information

Drug NameBerotralstat
Drug Alias NameBerotralstatumBerotralstat dihydrochlorideORLADEYOBCX-7353
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasma kallikrein inhibitors
TargetsPlasma kallikrein
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsAngioedemas, Hereditary
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2020/12/03
Country/TerritoryCzechiaCanadaUnited States +[29] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrphanpacificPint Pharma GmbHBiocryst Pharmaceuticals Inc +[6] 
Inactive CompaniesN/A
Active IndicationsAngioedemas, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeB06AC
Related LinksWikipediaDrugBankKEGG